Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

TREPROSTINIL

FDA · NDA · 2026-04-03

AgencyFDA
Submission typeNDA
Action date2026-04-03
BrandTYVASO
SponsorUNITED THERAP
RouteINHALATION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:28.340Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:TREPROSTINIL:2026-04-03

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

TREPROSTINIL — approval | AEaH